← Home / AIMEI HEALTH TECHNOLOGY CO., LTD (AFJK)
Stock Analysis
AIMEI HEALTH TECHNOLOGY CO., LTD (AFJK)
AFJK
AFJK · Market data
12.04 +0.33%
Track AFJK in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when AFJK price is:
52W Range Position
5%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-08-02 16:44 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and invalidation levels before acting.
⚖️
✓
Fundamentals
Insufficient / Insufficient
✓
Price Structure
Vulnerable
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
—
↗
Break Above
Confirmation improves above resistance.
23.64
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below —
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
8
◆
M&A
HIGH
HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.
Aimei Health Technology Co., Ltd (NASDAQ: AFJK, AFJKU, AFJKR, the “Company”) announced today that it has terminated the Business Combination Agreement, dated as of June 19, 2024, as amended on June 6, 2025, with United Hydrogen Group Inc.
8-K Filing • SEC EDGAR
JUL
8
●
Material Agreement
HIGH
HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.
Aimei Health Technology Co., Ltd (NASDAQ: AFJK, AFJKU, AFJKR, the “Company”) announced today that it has terminated the Business Combination Agreement, dated as of June 19, 2024, as amended on June 6, 2025, with United Hydrogen Group Inc.
8-K Filing • SEC EDGAR
JUN
29
●
Management / Board
MEDIUM
AFJK board and management update
Julianne Huh, a director of Aimei Health Technology Co., Ltd (the “ Company ”), submitted a letter of resignation indicating her intention to resign as the Company’s director, effective June 24, 2026, which has been accepted by the board of directors of the Company (the “ Board ”).
8-K Filing • SEC EDGAR
What's Driving AFJK?
📈 Technical recovery is improving
Momentum is Neutral. Watch 23.64 for confirmation and — for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
—
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
24.0
◎
How to read this setup
The nearest decision zone is framed by support around 11.36 and resistance near 23.64. The chart still needs to reclaim resistance to improve meaningfully, while any loss of support would keep weakness in control.
Price Chart
AFJK — 1D Chart
Open Full Workspace
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
↗
Revenue Growth
Insufficient
●
Profitability
Insufficient
≈
Cash Flow
Recovering
⚖
Balance Sheet
Strong
📈 Net Income
45,440
≈ Insufficient
AIMEI HEALTH TECHNOLOGY CO., LTD
Related Opportunities